sulfinpyrazone has been researched along with Body Weight in 7 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prophylactic effects of sulfinpyrazone (100 mg/Kg), aspirin (5 mg/Kg, 50 mg/Kg), and propranolol (2 mg/Kg, 10 mg/Kg) on myocardial necrosis and hypertrophy induced by isoproterenol were examined." | 7.66 | Effects of sulfinpyrazone, aspirin and propranolol on the isoproterenol-induced myocardial necrosis. ( Hashimoto, H; Ogawa, K, 1981) |
| "Prophylactic effects of sulfinpyrazone (100 mg/Kg), aspirin (5 mg/Kg, 50 mg/Kg), and propranolol (2 mg/Kg, 10 mg/Kg) on myocardial necrosis and hypertrophy induced by isoproterenol were examined." | 3.66 | Effects of sulfinpyrazone, aspirin and propranolol on the isoproterenol-induced myocardial necrosis. ( Hashimoto, H; Ogawa, K, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hilliker, KS | 1 |
| Roth, RA | 1 |
| Hashimoto, H | 1 |
| Ogawa, K | 1 |
| Cairncross, KD | 1 |
| Bassett, JR | 1 |
| Martin, C | 1 |
| Pannebakker, MA | 1 |
| den Ottolander, GJ | 1 |
| ten Pas, JG | 1 |
| Rosenkranz, B | 1 |
| Fejes-Tóth, G | 1 |
| Diener, U | 1 |
| Frölich, JC | 1 |
| Nakamura, H | 1 |
| Soji, Y | 1 |
| Masuda, Y | 1 |
| Nakamura, K | 1 |
| Günther, R | 1 |
| Herbst, M | 1 |
| Knapp, E | 1 |
| Siller, K | 1 |
1 trial available for sulfinpyrazone and Body Weight
| Article | Year |
|---|---|
Insulin requirements in diabetic patients treated with sulphinpyrazone.
Topics: Adult; Aged; Body Weight; Diabetes Mellitus; Diabetic Nephropathies; Double-Blind Method; Drug Inter | 1979 |
6 other studies available for sulfinpyrazone and Body Weight
| Article | Year |
|---|---|
Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydrallazine, dexamethasone or sulphinpyrazone.
Topics: Animals; Body Weight; Cardiomegaly; Dexamethasone; Heart Diseases; Hydralazine; L-Lactate Dehydrogen | 1984 |
Effects of sulfinpyrazone, aspirin and propranolol on the isoproterenol-induced myocardial necrosis.
Topics: Animals; Aspirin; Body Weight; Creatine Kinase; Cyclic AMP; Heart; Isoproterenol; Male; Myocardial I | 1981 |
The effect of sulfinpyrazone on morphological changes in the coronary vasculature induced by prolonged unpredictable stress in the rat.
Topics: Animals; Body Weight; Coronary Vessels; Corticosterone; Male; Rats; Stress, Physiological; Sulfinpyr | 1979 |
Effects of sulfinpyrazone on renal function and prostaglandin formation in man.
Topics: Adult; Angiotensin II; Blood Pressure; Body Weight; Creatinine; Depression, Chemical; Female; Glomer | 1985 |
Pharmacological studies of a new anti-inflammatory drug, 1-phenylsulfonyl-5,5-diphenylhydantoin (PC-796) in experimental animals. II. Toxicological and general pharmacological properties.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Autonomic Nervous System; Blood Circulation; Blood Gluco | 1970 |
[On the influence of Anturan on ric acid and plasma lipids in patients with gout].
Topics: Adult; Age Factors; Aged; Animals; Body Weight; Cholesterol; Diet Therapy; Fatty Acids, Nonesterifie | 1968 |